Provides the 2026 AHA/ACC de novo clinical practice guidelines for the evaluation and management of acute pulmonary embolism in adults.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“There have been significant advances in the understanding of pulmonary embolism and treatments to effectively manage this condition.”
“This 2026 update and expansion of the guidelines for the management of PE is a masterwork of guideline production, and is important for those managing patients with acute PE and developing care systems to expedite acute emergency management principles.”
“We possess powerful tools that undeniably improve acute hemodynamics and imaging endpoints, yet we lack the definitive data to prove they improve patient lives.”
Standardizes acute PE evaluation and management for clinicians; extends prior evidence with first de novo AHA/ACC framework.
Guideline Title: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults. Release Date: February 19, 2026. Prior Version(s): None; de novo guideline. Developer: American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, in collaboration with multiple partner societies including the Society of Hospital Medicine. Target Population: Adults aged 18 years or older with acute pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Nilesh Patel (2026) studied acute pulmonary embolism. Guideline for evaluation and management was evaluated. The 2026 AHA/ACC joint committee guideline provides de novo recommendations for the evaluation and management of acute pulmonary embolism in adults.
Synapse has enriched 10 related papers. Consider them for comparative context: